Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial
Birkeland E, Gharagozlian S, Birkeland KI, Valeur J, Mage I, Rud I, Aas AM
Published in European Journal of Nutrition
Methodology
Randomised controlled crossover trial of inulin-type fructans 16 g daily for 6 weeks in adults with type 2 diabetes with faecal microbiota sequencing and SCFA measurement
Key Findings
Inulin significantly increased Bifidobacterium abundance but did not change faecal short-chain fatty acid concentrations or glycaemic markers.
Conclusions
Inulin reliably shifts the microbiota toward bifidobacteria without guaranteeing metabolic change.
Limitations
Small sample; short intervention; faecal SCFA is an imperfect proxy for colonic production.
Supplements Studied
Inulin significantly increased Bifidobacterium abundance but did not change faecal short-chain fatty acid concentrations or glycaemic markers.
Outcomes Measured
Inulin significantly increased Bifidobacterium abundance but did not change faecal short-chain fatty acid concentrations or glycaemic markers.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.